These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 38204608)
1. Application of quantitative orbital analysis to assess the activity of Graves' ophthalmopathy. Li S; Liu YJ Am J Nucl Med Mol Imaging; 2023; 13(6):259-268. PubMed ID: 38204608 [TBL] [Abstract][Full Text] [Related]
2. New Multi-Parameters Combination of Technetium-99m-Diethylene-Triamine-Pentaacetate Orbital Single-Photon Emission Computed Tomography/Computed Tomography for the Evaluation of Graves' Orbitopathy Activity. Sun L; Peng R; Sun R Semin Ophthalmol; 2024 Jul; 39(5):387-393. PubMed ID: 38411131 [TBL] [Abstract][Full Text] [Related]
3. The value of SPECT/CT imaging of lacrimal glands as a means of assessing the activity of Graves' orbitopathy. Zhao RX; Shi TT; Luo S; Liu YF; Xin Z; Yang JK Endocr Connect; 2022 Feb; 11(2):. PubMed ID: 35015696 [TBL] [Abstract][Full Text] [Related]
4. [Efficacy of 99mTc-DTPA orbital SPECT/CT on the evaluation of lacrimal gland inflammation in patients with thyroid associated ophthalmopathy]. Jiang C; Li X; Zhao M; Dend H; Huang J; Liu D; Xu X Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Mar; 44(3):322-328. PubMed ID: 30971526 [TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of extraocular muscles in Graves' ophthalmopathy using T1 mapping. Zhu H; Zou M; Wu D; Li B; Su Y; Li Y; Hong S; Yang Z Eur Radiol; 2023 Dec; 33(12):9074-9083. PubMed ID: 37466707 [TBL] [Abstract][Full Text] [Related]
6. 99mTc-DTPA SPECT/CT provided guide on triamcinolone therapy in Graves' ophthalmopathy patients. Liu D; Xu X; Wang S; Jiang C; Li X; Tan J; Deng Z Int Ophthalmol; 2020 Mar; 40(3):553-561. PubMed ID: 31792849 [TBL] [Abstract][Full Text] [Related]
7. [Evaluation of inflammatory activity in thyroid associated ophthalmopathy by SPECT/CT with 99mTc-DTPA]. Liu D; Xu X; Wen D; Tan J; Jiang C Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 43(4):457-460. PubMed ID: 29774886 [TBL] [Abstract][Full Text] [Related]
8. SPECT using 99mTc-DTPA for the assessment of disease activity in Graves' ophthalmopathy: a comparison with the results from MRI. Galuska L; Leovey A; Szucs-Farkas Z; Garai I; Szabo J; Varga J; Nagy EV Nucl Med Commun; 2002 Dec; 23(12):1211-6. PubMed ID: 12464787 [TBL] [Abstract][Full Text] [Related]
9. Imaging of disease activity in Graves' orbitopathy with different methods: comparison of (99m)Tc-DTPA and (99m)Tc-depreotide single photon emission tomography, magnetic resonance imaging and clinical activity scores. Galuska L; Leovey A; Szucs-Farkas Z; Szabados L; Garai I; Berta A; Balazs E; Varga J; Nagy EV Nucl Med Commun; 2005 May; 26(5):407-14. PubMed ID: 15838422 [TBL] [Abstract][Full Text] [Related]
10. Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy. Colao A; Lastoria S; Ferone D; Pivonello R; Macchia PE; Vassallo P; Bonavolonta G; Muto P; Lombardi G; Fenzi G J Clin Endocrinol Metab; 1998 Nov; 83(11):3790-4. PubMed ID: 9814448 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of (99m)Tc-EDDA/HYNIC-TOC SPECT/CT scintigraphy in Graves' ophthalmopathy. Zhao R; Wang J; Deng J; Yang W; Wang J Am J Nucl Med Mol Imaging; 2012; 2(2):242-7. PubMed ID: 23133815 [TBL] [Abstract][Full Text] [Related]
13. The impact of 99mTc-DTPA orbital SPECT in patient selection for external radiation therapy in Graves' ophthalmopathy. Szabados L; Nagy EV; Ujhelyi B; Urbancsek H; Varga J; Nagy E; Galuska L Nucl Med Commun; 2013 Feb; 34(2):108-12. PubMed ID: 23196678 [TBL] [Abstract][Full Text] [Related]
14. Tc-99m polyclonal human immunoglobulin G imaging in Graves' ophthalmopathy. Durak H; Söylev M; Durak I; Değirmenci B; Capa Kaya G; Uysal B Clin Nucl Med; 2000 Sep; 25(9):704-7. PubMed ID: 10983759 [TBL] [Abstract][Full Text] [Related]
15. Monitoring and Predicting Treatment Response of Extraocular Muscles in Grave's Orbitopathy by Jiang C; Deng Z; Huang J; Deng H; Tan J; Li X; Zhao M Front Med (Lausanne); 2021; 8():791131. PubMed ID: 34977092 [No Abstract] [Full Text] [Related]
16. 99mTc(V)-DMSA SPECT for the assessment of disease activity in Graves' ophthalmopathy. Reyhan M; Toygar O; Sukan A; Seydaoglu G; Bakiner OS; Aydin M; Yapar AF; Aktas A Nucl Med Commun; 2007 Oct; 28(10):775-81. PubMed ID: 17728607 [TBL] [Abstract][Full Text] [Related]
17. Retrobulbar 99mTc-diethylenetriamine-pentaacetic-acid uptake may predict the effectiveness of immunosuppressive therapy in Graves' ophthalmopathy. Ujhelyi B; Erdei A; Galuska L; Varga J; Szabados L; Balazs E; Bodor M; Cseke B; Karanyi Z; Leovey A; Mezosi E; Burman KD; Berta A; Nagy EV Thyroid; 2009 Apr; 19(4):375-80. PubMed ID: 19355827 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves' ophthalmopathy for assessment of disease activity. Jiang H; Wang Z; Xian J; Li J; Chen Q; Ai L Acta Radiol; 2012 Feb; 53(1):87-94. PubMed ID: 22184678 [TBL] [Abstract][Full Text] [Related]
19. (99m)Tc-HYNIC-TOC scintigraphy in evaluation of active Graves' ophthalmopathy (GO). Sun H; Jiang XF; Wang S; Chen HY; Sun J; Li PY; Ning G; Zhao YJ Endocrine; 2007 Jun; 31(3):305-10. PubMed ID: 17906380 [TBL] [Abstract][Full Text] [Related]
20. Deep learning-based diagnosis of disease activity in patients with Graves' orbitopathy using orbital SPECT/CT. Yao N; Li L; Gao Z; Zhao C; Li Y; Han C; Nan J; Zhu Z; Xiao Y; Zhu F; Zhao M; Zhou W Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3666-3674. PubMed ID: 37395800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]